title: Heterogeneous cardiac sympathetic innervation in heart failure after myocardial infarction of rats.
abstract: We examined cardiac neuronal function and beta-receptor with a dual-tracer method of [(131)I]meta-iodobenzylguanidine (MIBG) and [(125)I]iodocyanopindolol (ICYP) in rat heart failure after myocardial infarction (MI). In rats with MI, left ventricular (LV) systolic function decreased, and LV dimension and right ventricular (RV) mass increased gradually. MIBG accumulations of the noninfarcted LV (remote region) and RV decreased by 15% at 1 wk compared with sham-operated rats, and these accumulations were restored by 71% and 56%, respectively, at 24 wk compared with age-matched sham rats despite sustained depletion of myocardial norepinephrine contents in these regions. ICYP accumulation of the remote region and of the RV did not decrease at any stages. Myocardial MIBG distribution was heterogeneous at 1 wk when it was lower in the peri-infarcted region than in the remote region, associated with reduced ICYP accumulation in the peri-infarcted region. The heterogeneous distribution of both isotopes disappeared at 12 wk. Thus cardiac sympathetic neuronal alteration was coupled with downregulation of beta-receptors in rat heart failure after MI. The abnormal adrenergic signaling occurred heterogeneously in terms of ventricular distribution and time course after MI.
authors.affiliation: The 2nd Department of Internal Medicine, Toyama Medical and Pharmaceutical University, Toyama 930-0194, Japan.
authors.forename: A
authors.initials: A
authors.lastname: Igawa
authors.forename: T
authors.initials: T
authors.lastname: Nozawa
authors.forename: N
authors.initials: N
authors.lastname: Yoshida
authors.forename: N
authors.initials: N
authors.lastname: Fujii
authors.forename: M
authors.initials: M
authors.lastname: Inoue
authors.forename: S
authors.initials: S
authors.lastname: Tazawa
authors.forename: H
authors.initials: H
authors.lastname: Asanoi
authors.forename: H
authors.initials: H
authors.lastname: Inoue
mesh_terms: D019797:3-Iodobenzylguanidine / Q000493:pharmacokinetics; D000818:Animals; D001794:Blood Pressure; D002908:Chronic Disease; D006321:Heart / Q000294:innervation*; D006333:Heart Failure / Q000000981:diagnostic imaging* / Q000503:physiopathology*; D007457:Iodine Radioisotopes / Q000493:pharmacokinetics; D020120:Iodocyanopindolol / Q000493:pharmacokinetics; D008297:Male; D009203:Myocardial Infarction / Q000503:physiopathology*; D009206:Myocardium / Q000737:chemistry; D009638:Norepinephrine / Q000032:analysis; D009929:Organ Size; D011877:Radionuclide Imaging; D051381:Rats; D017208:Rats, Wistar; D011941:Receptors, Adrenergic / Q000502:physiology; D013564:Sympathetic Nervous System / Q000502:physiology*; D014018:Tissue Distribution; D020257:Ventricular Remodeling / Q000502:physiology*
chemical_list: D007457:Iodine Radioisotopes; D011941:Receptors, Adrenergic; D019797:3-Iodobenzylguanidine; D020120:Iodocyanopindolol; D009638:Norepinephrine